Navigation Links
Israel's Prestigious President's Conference to Feature Oramed Pharmaceuticals' Revolutionary Oral Insulin Capsule
Date:5/6/2008

Oramed is one of 60 Companies Selected to Participate at the "Facing

Tomorrow" Conference Marking the Country's 60th Birthday

JERUSALEM, Israel, May 6 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP), a developer of oral delivery systems, has been selected for the first annual Presidential conference, "Facing Tomorrow," as one of the 60 "enterprises of tomorrow" representing the future face of Israel. The monumental event is being held to mark the country's sixtieth birthday.

Additionally, Oramed was one of six companies chosen to be featured in a video presentation at the conference's opening event. The conference will be attended by global political and business leaders, including Israeli Prime Minister Ehud Olmert, President George W. Bush and Google founder Sergey Brin.

"The selection of Oramed as one of the companies to change the face of tomorrow is a great honor," said Nadav Kidron, CEO of Oramed Pharmaceuticals. "Being chosen for the conference illustrates the potential of our technology to make a significant difference for millions of diabetics around the world."

The conference will be held May 13-15 at the Jerusalem International Convention Center.

For more information on the conference, please visit the conference's website at: http://www.presidentconf.org.il/en/

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is an Israeli-based company focused on the development of oral delivery solutions based on proprietary technology. Oramed is currently developing an orally ingestible insulin capsule for the treatment of diabetes. The oral administration of insulin is more physiological than the current delivery method, mimicking the natural path of insulin throughout the body. The company is also pursuing the development of oral delivery solutions for drugs and vaccines presently delivered via injection.


'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Fraunhofer and Boston University Hosted Prestigious SME Tour
2. Prestigious Scientific Leaders Join InterWest Advisory Committee
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. Launch of New, Prestigious Infertility and Gynaecology Research GrAnt (FRIGGA)
5. Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
6. Research by Case Western Reserve University, VA earns cover of prestigious science publication
7. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
8. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
9. Prestigious Bioethics Award for Scholar from Mexico
10. Physics professor lauded for NSF efforts with prestigious award
11. Physics professor lauded for NSF efforts with prestigious award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...within government channels, WEST PORT, Conn., and...c. (ABH) and Regenesis Biomedical, Inc. announced ...magraft(R) within the United,States (US) governmen...Regenesis will provide its specialized sales force...eran,s Administration (VA), Department of Defense,...
...ical,Services, Inc. (NYSE: WST ) today announced ...er 2008 cash dividend of $0.14 per share. The,divi...s of record on July,23, 2008., About West Pharmac...ces, Inc. is a global manufacturer of,components a... stoppers and,seals for vials, and closures and di...
...l/Mixed tropic HIV patients with ...May 7 Pathway Diagnostics announces,nationwide av...ular,SensiTrop(TM) II assay, combining the sensiti...) technology with the specificity of molecular,seq...atus of HIV infected,patients. Pathway performs th...
Other Biology Technology:Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 2Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 3Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay 2
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2Scientists think 'killer petunias' should join the ranks of carnivorous plants 2How nutrition affects healthy aging 2Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 12429 1Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 12429 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 1Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 3Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 1Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 2
...ion, Matches with Watch-list Databases and Reports...ch 9 Neurotechnology, a provider of high-precisio...ounced the availability of VeriLook Surveillance S...identification using live video streams from high-...riLook 3.2 SDK and other facial recognition system...
...ch 12 (OTC Bulletin Board: CICI) Communication In... a leading supplier of electronic signature soluti...al industry* and the recognized leader** in biomet...ancial results for the fourth quarter and the year...the three months ended December 31, 2008 were $843...
...tion growth in southern Nevada has placed increasi...80% of the state,s residents lived in southern Nev...eople. The dual concerns of this population boom a... conditions has created an urgent demand for offic... meet resident and visitor demand., Las Vegas oper...
Other Biology News:VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 2VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 6Keeping golf courses green when fresh water is limited 2Keeping golf courses green when fresh water is limited 3
Anti-Histone H2B, acetyl (Lys20) Antibody, Unconjugated from Cell Signaling Technology
Rhodamine-B-isothiocyanate from Research Organics, Inc.
Rabbit Anti-Human MMP-7, aminoterminal end active enzyme, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-CD42d Monoclonal Antibody, Unconjugated, Clone CLB-SW16 (formerly 708) from Abcam
Biology Products: